Artikkelit - Trepo

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Hugosson, Jonas; Roobol, Monique J.; Månsson, Marianne; Tammela, Teuvo; Auvinen, Anssi et al. (2019)
article

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Fizazi, Karim; Tran, NamPhuong; Fein, Luis; Matsubara, Nobuaki; Rodriguez-Antolin, Alfredo; Alekseev, Boris Y.; Özgüroğlu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; De Porre, Peter; Kheoh, Thian; Park, Youn C.; Todd, Mary B.; Chi, Kim N.; Tammela, Teuvo; for the LATITUDE Investigators (2017)
article

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

Brunner, C; Davies, NM; Martin, RM; Schleutker, Johanna; Auvinen, Anssi; Murtola, Teemu; Tammela, Teuvo et al. (2017)
article

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families

Bailey-Wilson, Joan; Childs, Erica; Cropp, Cheryl; Tammela, Teuvo; Schleutker, Johanna et al. (2012)
article

Background Genetic variants are likely to contribute to a portion of prostate cancer risk. Full elucidation of the genetic etiology of prostate cancer is difficult because of incomplete penetrance and genetic and ...

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men

Siltari, Aino; Murtola, Teemu; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo; Auvinen, Anssi (2020)
article

Apalutamide treatment and metastasis-free survival in prostate cancer

Smith, Matthew; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Graff, Julie; Olmos, David; Mainwaring, Paul; Lee, Ji Youl; Uemura, Hiroji; Lopez‑Gitlitz, Angela; Trudel, Géralyn; Espina, Byron; Shu, Youyi; Park, Youn; Rackoff, Wayne; Yu, Margaret; Small, Eric; Tammela, Teuvo; for the SPARTAN Investigators (2018)
article

Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer : statistical evaluation of epistasis

Chen, Li-Sheng; Fann, Jean Ching-Yuan; Chiu, Sherry Yueh-Hsia; Yen, Amy Ming-Fang; Wahlfors, Tiina; Tammela, Teuvo; Chen, Hsiu-Hsi; Auvinen, Anssi; Schleutker, Johanna (2014)
article

Understanding the impact of multiple genetic variants and their interactions on the disease penetrance of familial multiple prostate cancer is very relevant to the overall understanding of carcinogenesis. We assessed the ...

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

Gusev, Alexander; Shi, Huwenbo; Kichaev, Gleb; Schleutker, Johanna; Auvinen, Anssi; Murtola, Teemu; Tammela, Teuvo; Wahlfors, Tiina et al. (2016)
article

Although genome-wide association studies have identified over 100 risk loci that explain ~33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data ...

Bladder cancer survival in men using 5-alpha-reductase inhibitors

Mäkelä, Ville; Kotsar, Andres; Tammela, Teuvo; Murtola, Teemu (2018)
article

Cancer mortality does not differ by antiarrhythmic drug use : A population-based cohort of Finnish men

Kaapu, Kalle; Rantaniemi, Lauri; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo; Auvinen, Anssi; Murtola, Teemu (2018)
article

Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer

Vandekerkhove, Gillian; Struss, Werner; Annala, Matti; Kallio, Heini; Khalaf, Daniel; Warner, Evan; Herberts, Cameron; Ritch, Elie; Beja, Kevin; Loktionova, Yulia; Hurtado-Coll, Antonio; Fazli, Ladan; So, Alan; Black, Peter; Nykter, Matti; Tammela, Teuvo; Chi, Kim; Gleave, Martin; Wyatt, Alexander (2019)
article

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

Kallio, Heini; Hieta, Reija; Latonen, Leena; Brofeldt, Anniina; Annala, Matti; Kivinummi, Kati; Tammela, Teuvo; Nykter, Matti; Isaacs, William; Lilja, Hans; Bova, Steven; Visakorpi, Tapio (2018)
article

Cost-effectiveness analysis of PSA-based mass screening : Evidence from a randomised controlled trial combined with register data

Booth, Neill; Rissanen, Pekka; Tammela, Teuvo; Kujala, Paula; Stenman, Ulf-Håkan; Taari, Kimmo; Talala, Kirsi; Auvinen, Anssi (2019)
article

Costs of screening for prostate cancer : evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data

Booth, Neill; Rissanen, Pekka; Tammela, Teuvo; Taari, Kimmo; Talala, Kirsi; Auvinen, Anssi (2018)
article

Darolutamide in nonmetastatic, castration-resistant prostate cancer

Fizazi, Karim; Shore, Neal; Tammela, Teuvo; Ulys, Albertas; Vjaters, Egils; Polyakov, Sergey; Jievaltas, Mindaugas; Luz, Murilo; Alekseev, Boris; Kuss, Iris; Kappeler, Christian; Snapir, Amir; Sarapohja, Toni; Smith, Matthew; for the ARAMIS Investigators (2019)
article

Elevated post-void residual volume in a geriatric post-hip fracture assessment in women-associated factors and risk of mortality

Nuotio, Maria S.; Luukkaala, Tiina; Tammela, Teuvo (2019)
article

Enzalutamide in metastatic prostate cancer before chemotherapy

Beer, Tomasz; Armstrong, Andrew; Rathkopf, Dana; Tammela, Teuvo et al. (2014)
article

BACKGROUND: Enzalutamide is an oral androgen-receptor inhibitor that prolongs survival in men with metastatic castration-resistant prostate cancer in whom the disease has progressed after chemotherapy. New treatment ...

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer

Kaukoniemi, Kirsti; Rauhala, Hanna; Scaravilli, Mauro; Latonen, Leena; Annala, Matti; Vessella, Robert; Nykter, Matti; Tammela, Teuvo; Visakorpi, Tapio (2015)
article

Micro-RNAs (miRNA) are important regulators of gene expression and often differentially expressed in cancer and other diseases. We have previously shown that miR-193b is hypermethylated in prostate cancer (PC) and suppresses ...

Eturauhasen liikakasvu

Tammela, Teuvo (2017)
contributionToPeriodical

Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer : Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

Shore, Neal; Zurth, Christian; Fricke, Robert; Gieschen, Hille; Graudenz, Kristina; Koskinen, Mikko; Ploeger, Bart; Moss, Jonathan; Prien, Olaf; Borghesi, Gustavo; Petrenciuc, Oana; Tammela, Teuvo; Kuss, Iris; Verholen, Frank; Smith, Matthew; Fizazi, Karim (2019)
article

"Tammela, Teuvo" - Selaus tekijän mukaan Artikkelit

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer ﻿

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer ﻿

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study ﻿

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families ﻿

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men ﻿

Apalutamide treatment and metastasis-free survival in prostate cancer ﻿

Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer : statistical evaluation of epistasis ﻿

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation ﻿

Bladder cancer survival in men using 5-alpha-reductase inhibitors ﻿

Cancer mortality does not differ by antiarrhythmic drug use : A population-based cohort of Finnish men ﻿

Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer ﻿

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases ﻿

Cost-effectiveness analysis of PSA-based mass screening : Evidence from a randomised controlled trial combined with register data ﻿

Costs of screening for prostate cancer : evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data ﻿

Darolutamide in nonmetastatic, castration-resistant prostate cancer ﻿

Elevated post-void residual volume in a geriatric post-hip fracture assessment in women-associated factors and risk of mortality ﻿

Enzalutamide in metastatic prostate cancer before chemotherapy ﻿

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer ﻿

Eturauhasen liikakasvu ﻿

Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer : Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial ﻿